Institutional investors purchased a net $858.1 thousand shares of ABMD during the quarter ended March 2018 and now own 90.02% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WINSLOW CAPITAL MANAGEMENT LLC Bought 785.1 Thousand shares of Abiomed Inc
FRANKLIN ADVISERS, INC. Bought 297.2 Thousand shares of Abiomed Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 242.2 Thousand shares of Abiomed Inc